Introduction: Thermal ablation (TA) is increasingly used as a treatment for localized renal masses (LRMs, <4 cm) especially in older or comorbid patients. Our previous article by Mershon et al., highlighted the safety and efficacy of TA for treatment of LRMs in select patients. In this presentation, we update that work and discuss new frontiers for TA including patient selection, procedural improvements, and outcomes.